Search for: "POM Wonderful LLC v. FTC"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
1 Feb 2015, 11:05 am
Circuit issued its opinion in POM Wonderful, LLC, et al. v. [read post]
5 Mar 2012, 4:19 pm
We previously reported that on September 13, 2010, POM Wonderful LLC (“POM”) filed a complaint in court against the FTC, alleging that the FTC was applying a new and legally unwarranted substantiation standard to POM's claims. [read post]
22 May 2012, 6:30 am
In the Matter of POM Wonderful LLC and Roll Global LLC, FTC File No. 082-3122 (May 21, 2012) Bottom line: while rejecting complaint counsel’s arguments that double-blind, randomized clinical trials were required to substantiate health claims of the sort made by Pom, the ALJ found that Pom didn’t meet the somewhat lower standard of reliable and competent scientific evidence either with respect to claims about heart… [read post]
23 Mar 2016, 11:29 am
Pom Wonderful LLC v. [read post]
3 Feb 2015, 1:12 pm
POM Wonderful, LLC v. [read post]
2 Feb 2015, 8:59 am
POM Wonderful, LLC v. [read post]
6 May 2016, 11:23 am
POM Wonderful LLC v. [read post]
1 Apr 2014, 12:34 pm
In re Pom Wonderful LLC Marketing and Sales Practices Litigation, No. [read post]
9 Feb 2015, 9:11 am
POM Wonderful’s advertising claims were false and deceptive. [read post]
14 Feb 2011, 1:40 pm
See FTC v. [read post]
25 May 2011, 12:44 am
Last year, POM Wonderful LLC ("POM") sued FTC claiming that these additional requirements exceeded FTC’s authority and constitute a violation of an advertiser’s First Amendment rights. [read post]
9 Feb 2015, 2:26 pm
See FTC v Genesis, Stipulated Judgment (Jan. 27, 2015). [read post]
6 Apr 2016, 8:31 am
FTC Opposes POM’s Bid for the Supreme Court to Review Ad Dispute The FTC filed a brief in POM Wonderful v. [read post]
24 Apr 2013, 8:31 am
Regenerative Sciences LLC, 878 F. [read post]
4 Jun 2019, 10:20 am
Pom Wonderful: also looked at multiple factors about what constituted commercial speech. [read post]
9 Mar 2020, 1:21 pm
· Molly Burich, Director of Public Policy, Boehringer Ingelheim · Surya Singh, President, Singh Healthcare Advisors, LLC Moderated Panel Discussion Meredyth Andrus, Attorney, Health Care Division, Bureau of Competition, FTC Does the designation of interchangeability still have value in the US? [read post]
25 Feb 2019, 8:35 am
Danone, US, LLC v. [read post]
